Grants
All grants
3,644 results · page 181 of 183
- R3PEATS Multi-Team Triangulation: Collaborative Cross-Method Approaches to Scientific Discovery (RM1)US$5,000,000
- R3PEATS Rigor Scholar Cohort Awards (K12)US$4,250,000
- Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (R24 Clinical Trial Not Allowed)
- Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)
- Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)
- Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)
- Mechanistic Toxicology of METALS: Metal Exposure, Transport, Action, Localization, and Susceptibility (RP1 Clinical Trial Not Allowed)US$15,000,000
- Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)US$20,000,000
- Technology Development Program
- Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)
- FY2026/2027 Community Compass Technical Assistance and Capacity Building Program Notice of Funding OpportunityUS$115,640,000
- Research to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral Sciences
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)US$320,000
- Collaborative Centers in Children’s Environmental Health Research and Translation (P2C Clinical Trial Optional)US$10,000,000
- Immune Drivers of Autoimmune DiseaseUS$3,600,000
- The Role of the Innate Immune System in the Pathogenesis of Type 1 DiabetesUS$15,000,000
- Partnerships for Advancing Development of Diagnostics for Infectious DiseasesUS$10,000,000
- Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)
- LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE)